Genomic testing is integral across all areas of health care and is a cornerstone of modern medicine. Beyond diagnosing rare conditions, genomic testing is routinely used to inform reproductive and prenatal care, augment risk assessments, guide therapies and inform management at the individual and public health level. There are over 25 conditions with federally funded Medicare Benefits Schedule (MBS) item numbers to deliver germline diagnostic genomic testing, including cancers, cardiac conditions, renal conditions and childhood hearing loss. Additional genomic testing is funded by state and territory public health departments and private out‐of‐pocket payments. The exponential growth of genomics knowledge and use in health care is likely to continue. Given its clinical value, genomic testing is increasingly offered by clinicians who do not have genetics subspecialty qualifications (referred to as non‐genetics clinicians), which has necessitated further education and upskilling of these clinicians. Although mainstreaming has been successful in some settings,1 most health services and clinicians are insufficiently prepared or resourced to address the complexities of genomic medicine.2,3
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Jayasinghe K, Biros E, Harris T, et al. Implementation and evaluation of a national multidisciplinary kidney genetics clinic network over ten years. Kidney Int Rep 2024; 9: 2372‐2385.
- 2. Crellin E, McClaren B, Nisselle A, et al. Preparing medical specialists to practice genomic medicine: education an essential part of a broader strategy. Front Genet 2019; 10: 789.
- 3. O'Shea R, Ma AS, Jamieson RV, Rankin NM. Precision medicine in Australia: now is the time to get it right. Med J Aust 2022; 217: 559‐563. https://www.mja.com.au/journal/2022/217/11/precision‐medicine‐australia‐now‐time‐get‐it‐right
- 4. Mordaunt DA, Dalziel K, Goranitis I, Stark Z. Uptake of funded genomic testing for syndromic and non‐syndromic intellectual disability in Australia. Eur J Hum Genet 2023; 31: 977‐979.
- 5. Watts GF, Sullivan DR, Hare DL, et al. Integrated guidance for enhancing the care of familial hypercholesterolaemia in Australia. Heart Lung Circ 2021; 30: 324‐349.
- 6. Morrow A, Steinberg J, Chan P, et al. In person and virtual process mapping experiences to capture and explore variability in clinical practice: application to genetic referral pathways across seven Australian hospital networks. Transl Behav Med 2023; 13: 561‐570.
- 7. Shaw T, Fok R, Courtney E, et al. Missed diagnosis or misdiagnosis: common pitfalls in genetic testing. Singapore Med J 2023; 64: 67‐73.
- 8. Farmer MB, Bonadies DC, Pederson HJ, et al. Challenges and errors in genetic testing: the fifth case series. Cancer J 2021; 27: 417‐422.
- 9. Ackerman JP, Bartos DC, Kapplinger JD, et al. The promise and peril of precision medicine: phenotyping still matters most. Mayo Clin Proc 2016: S0025‐6196(16)30463‐3.
- 10. Ray T. Genetic testing challenges in oncology: immigrant mislabeled as BRCA‐Positive, regrets ovary removal. May 2021. Precision Medicine Online. https://www.precisionmedicineonline.com/molecular‐diagnostics/genetic‐testing‐challenges‐oncology‐immigrant‐mislabeled‐brca‐positive (viewed Oct 2024).
- 11. Bhatia A, Kliff S. When they warn of rare disorders, these prenatal tests are usually wrong. The New York Times, 1 Jan 2022. https://www.nytimes.com/2022/01/01/upshot/pregnancy‐birth‐genetic‐testing.html (viewed Oct 2024).
- 12. Bennett C. Ambiguous genetic test results can be unsettling. Worse, they can lead to needless surgeries. The Washington Post, 7 Feb 2021. https://www.washingtonpost.com/health/genetic‐tests‐uncertain‐results/2021/02/05/80a06d9a‐65a2‐11eb‐8468‐21bc48f07fe5_story.html (viewed Oct 2024).
- 13. Ma A, Newing TP, O'Shea R, et al. Genomic multidisciplinary teams: a model for navigating genetic mainstreaming and precision medicine. J Paediatr Child Health 2024; 60: 118‐124.
- 14. Kohut K, Limb S, Crawford G. The changing role of the genetic counsellor in the genomics era. Current Genetic Medicine Reports 2019; 7: 75‐84.
- 15. Austin J. 2020 Vision: genetic counselors as acknowledged leaders in integrating genetics and genomics into healthcare. J Genet Couns 2016; 25: 1‐5.
- 16. Smerecnik CM, Mesters I, Verweij E, et al. A systematic review of the impact of genetic counseling on risk perception accuracy. J Genet Couns 2009; 18: 217‐228.
- 17. Rutherford S, Zhang X, Atzinger C, et al. Medical management adherence as an outcome of genetic counseling in a pediatric setting. Genet Med 2014; 16: 157‐163.
- 18. Athens BA, Caldwell SL, Umstead KL, et al. A systematic review of randomized controlled trials to assess outcomes of genetic counseling. J Genet Couns 2017; 26: 902‐933.
- 19. Kentwell M, Dow E, Antill Y, et al. Mainstreaming cancer genetics: a model integrating germline BRCA testing into routine ovarian cancer clinics. Gynecol Oncol 2017; 145: 130‐136.
- 20. Semaka A, Austin J. Patient perspectives on the process and outcomes of psychiatric genetic counseling: an “empowering encounter”. J Genet Couns 2019; 28: 856‐868.
- 21. Miller CE, Krautscheid P, Baldwin EE, et al. Genetic counselor review of genetic test orders in a reference laboratory reduces unnecessary testing. Am J Med Genet A 2014; 164A: 1094‐1101.
- 22. Haidle JL, Sternen DL, Dickerson JA, et al. Genetic counselors save costs across the genetic testing spectrum. Am J Manag Care 2017; 23: Sp428‐Sp430.
- 23. Yanes T, Sullivan A, Barbaro P, et al. Evaluation and pilot testing of a multidisciplinary model of care to mainstream genomic testing for paediatric inborn errors of immunity. Eur J Hum Genet 2023; 31: 1125‐1132.
- 24. Coleman TF, Pugh J, Kelley WV, et al. Errors in genome sequencing result disclosures: a randomized controlled trial comparing neonatology non‐genetics healthcare professionals and genetic counselors. Genet Med 2024; 26: 101198.
- 25. McInerney‐Leo AM, Schmidts M, Cortés CR, et al. Short‐rib polydactyly and Jeune syndromes are caused by mutations in WDR60. Am J Hum Genet 2013; 93: 515‐523.
- 26. Tiller J, Bakshi A, Dowling G, et al. Community concerns about genetic discrimination in life insurance persist in Australia: a survey of consumers offered genetic testing. Eur J Hum Genet 2024; 32: 286‐294.
- 27. Leslie F, Avis SR, Bagnall RD, et al. The New South Wales Sudden Cardiac Arrest Registry: a data linkage cohort study. Heart Lung Circ 2023; 32: 1069‐1075.
- 28. Human Genetics Society of Australasia. Genetic counselling training and accreditation 2024 [website]. https://hgsa.org.au/Web/Web/ET/Genetic‐Counselling.aspx?hkey=975b23ce‐fa8e‐485a‐a7ee‐fc88aab9a60d (viewed July 2024).
- 29. Nisselle A, Macciocca I, McKenzie F, et al. Readiness of clinical genetic healthcare professionals to provide genomic medicine: an Australian census. J Genet Couns 2019; 28: 367‐377.
- 30. Kanga‐Parabia A, Mitchell L, Smyth R, et al. Genetic counseling workforce diversity, inclusion, and capacity in Australia and New Zealand. Genetics in Medicine Open 2024; 101848.
- 31. Caleshu C, Kim H, Silver J, et al. Contributors to and consequences of burnout among clinical genetic counselors in the United States. J Genet Couns 2022; 31: 269‐278.
- 32. Medicare Benefits Schedule (MBS) Review Advisory Committee. Genetic Counselling Final Report 2022. https://www.health.gov.au/sites/default/files/2023‐04/mbs‐review‐advisory‐committee‐genetic‐counselling‐final‐report_0.pdf (viewed July 2024).
- 33. Hoskins C, Gaff C, McEwen A, et al. Professional regulation for Australasian genetic counselors. J Genet Couns 2021; 30: 361‐369.
- 34. Patrinos D, Ghaly M, Al‐Shafai M, Zawati MH. Legal approaches to risk of harm in genetic counseling: perspectives from Quebec and Qatar. Front Genet 2023; 14: 1190421.
No relevant disclosures.